AOD 9604 (5mg)
Metabolic Research
Research Use Only — Not for Human or Veterinarian Administration

AOD 9604 (5mg)

AOD-9604 is a modified fragment of human growth hormone (amino acids 176–191) studied in research models for lipolytic activity without the somatogenic effects of full-length GH.

AOD 9604 (5mg)$34.00
View only
View Certificate of AnalysisThird-party HPLC lab report · opens PDF

Mechanism of Action

AOD-9604 mimics the lipolytic domain of GH, activating beta-3 adrenergic receptors and downstream fat metabolism pathways in adipocyte research models without significant IGF-1 elevation.

Research Applications

  • Adipocyte lipolysis assays
  • Beta-3 adrenergic receptor studies
  • Comparative GH fragment research

Specifications

sequenceH-Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-OH (modified fragment)
molecular Weight1815.1 Da
cas221231-10-3
appearanceWhite lyophilized powder

Reconstitution (Laboratory)

Reconstitute with bacteriostatic water. Standard sterile technique.

Storage & Handling

Lyophilized: 2–8 °C. Reconstituted: refrigerate.

Quality Assurance

Every lot undergoes independent third-party HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing (<0.5 EU/mg). Certificate of Analysis (COA) is stored against the SKU lot number and available through your research account portal.

Sources & References

  1. 1.Heffernan MA, et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism. J Endocrinol. 2001. · PubMed →
  2. 2.Ng FM, et al. Metabolic studies of a synthetic lipolytic domain of human growth hormone. Horm Res. 2000. · PubMed →